# TAVNEOS
> **NDA214487** · New Drug Application · Sponsor: CHEMOCENTRYX · Approved 2021-10-07
## Drug
- **FDA Application Number:** NDA214487
- **Application type:** New Drug Application
- **Brand name:** TAVNEOS
- **Generic name:** AVACOPAN
- **Active ingredients:** AVACOPAN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHEMOCENTRYX
- **Manufacturer:** ChemoCentryx, Inc.
- **First approval:** 2021-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214487)
---
*MORVS · CC0 1.0*